- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Diabetic macular oedema
- Meeting Date: November 2020
- Public Summary Document (PSD) November 2020 PBAC Meeting - (PDF 965KB)
- Public Summary Document (PSD) November 2020 PBAC Meeting - (Word 65KB)
Fluocinolone acetonide – November 2020
Fluocinolone acetonide: Intravitreal injection 190 micrograms; Iluvien®
Last updated
19 March 2021